Cargando…

Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response

Although clinical response to primary chemotherapy in stage II and III breast cancer is associated with a survival advantage, it is the degree of pathological response in the breast and ipsilateral axilla that best identifies patients with a good long-term outcome. A mathematical model of the initia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cameron, D A, Gregory, W M, Bowman, A, Anderson, E D C, Levack, P, Forouhi, P, Leonard, R C F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374548/ https://www.ncbi.nlm.nih.gov/pubmed/10883676 http://dx.doi.org/10.1054/bjoc.2000.1216

Ejemplares similares

Mathematical modelling of tumour response in primary breast cancer.
por: Cameron, D. A., et al.
Publicado: (1996)

Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
por: Cameron, D. A., et al.
Publicado: (1997)

Primary tumour characteristics and axillary lymph node status in breast cancer
por: Yiangou, C, et al.
Publicado: (1999)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis
por: Abudu, A, et al.
Publicado: (1999)

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas
por: Ray-Coquard, I, et al.
Publicado: (2001)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
por: Fosså, A, et al.
Publicado: (2000)

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
por: Bottini, A, et al.
Publicado: (2001)

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
por: Paradiso, A, et al.
Publicado: (2000)

Microsatellite instability in thyroid tumours and tumour-like lesions
por: Lazzereschi, D, et al.
Publicado: (1999)

White matter hyperintensities relate to executive dysfunction, apathy, but not disinhibition in long-term adult survivors of pediatric cerebellar tumor
por: Haller, Olivia C., et al.
Publicado: (2021)

DNA analysis of breast tumour fine needle aspirates using flow cytometry.
por: Levack, P. A., et al.
Publicado: (1987)

Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases
por: Palmieri, G, et al.
Publicado: (2000)

Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours
por: Bergman, L, et al.
Publicado: (2000)

Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes
por: Angelis, P M De, et al.
Publicado: (1999)

Chemotherapy for unresectable and recurrent intramedullary glial tumours in children
por: Doireau, V, et al.
Publicado: (1999)

Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation
por: Thews, O, et al.
Publicado: (2000)

Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening
por: Castleberry, A W, et al.
Publicado: (2009)

Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor
por: Albo, D, et al.
Publicado: (2000)

Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours
por: Napier, M P, et al.
Publicado: (2000)

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
por: Mitry, E, et al.
Publicado: (1999)

Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
por: Hammerlid, E, et al.
Publicado: (2001)

The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study
por: Mitchell, C, et al.
Publicado: (2000)

Oestrogen receptor-α variant mRNA expression in primary human breast tumours and matched lymph node metastases
por: Leygue, E, et al.
Publicado: (1999)

Trafficking of ‘immune’ CD4(+)/CD8(+) T-lymphocytes into the RENCA tumour microcirculation in vivo in mice
por: Ali, S A, et al.
Publicado: (2000)

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
por: Pratesi, G, et al.
Publicado: (1999)

Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer
por: Magdalena, C, et al.
Publicado: (2000)

A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours
por: Bernini, G P, et al.
Publicado: (2001)

p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours
por: Le Frère-Belda, M A, et al.
Publicado: (2001)

Minisatellite instability is found in colorectal tumours with mismatch repair deficiency
por: Coleman, M G, et al.
Publicado: (2001)

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
por: Qiu, L, et al.
Publicado: (1999)

Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)
por: Oberlin, O, et al.
Publicado: (2001)

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000)

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours
por: Curmi, P A, et al.
Publicado: (2000)

Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel
por: Veitia, R, et al.
Publicado: (2000)

High prevalence of p16 genetic alterations in head and neck tumours
por: Miracca, E C, et al.
Publicado: (1999)

Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy
por: Sheridan, M T, et al.
Publicado: (2000)

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
por: Anderson, E. D., et al.
Publicado: (1989)

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours
por: Jefferies, S, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_3ho6p5ma8mii077tb2c33dbt4v